This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated RAB8A Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-RAB8A WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~23.7 kDa | |
| Gel | 12–15% (standard starting point) | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Phosphorylated + Methylated | |
| Caveat | Phosphorylation-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 2 isoform(s) |
The M02180 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | HeLa cell lysate (catalog M02180) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Short semi-dry transfer; verify retention (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | M02180; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
Full-length RAB8A is predicted at 23.7 kDa; propeptide cleavage and isoforms could affect bands, but their migration effects are unproven.
| Band near 23.7 kDa | Consistent with the predicted full-length RAB8A mass; identity requires confirmation |
| Band just below the precursor | Could reflect cleavage of the 205..207 propeptide; its migration is unverified |
| Multiple nearby bands | Could reflect isoforms 1 and 2; distinct migration is unverified |
| Stronger band in a membrane-enriched fraction | Consistent with lipid-anchored, membrane-associated RAB8A |
| Predicted full-length mass | 23.7 kDa is the sequence-based reference, not a measured migration |
| 205..207 propeptide cleavage | Could yield a slightly smaller mature protein; migration is unverified |
| Isoform 1 | May differ in size from isoform 2; relative size is unknown |
| Isoform 2 | May differ in size from isoform 1; relative size is unknown |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Lipid-anchored RAB8A may be poorly recovered from membranes | Check membrane extraction and a membrane-enriched fraction |
| Band higher than expected | The supplied features do not establish a higher migrating RAB8A species | Check the size marker and confirm band identity by RAB8A depletion |
| Band lower than expected | Propeptide cleavage could cause a small decrease; a large decrease remains unexplained | Confirm identity by RAB8A depletion and assess sample degradation |
| Multiple bands | Isoforms 1 and 2 exist, but distinct band sizes are unverified | Test which bands respond to RAB8A depletion |
| Weak or no signal | Membrane-associated RAB8A may be underrepresented after extraction | Check extraction efficiency and antibody performance with a positive lysate |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Deeper troubleshooting and optimisation questions for RAB8A, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
Both listed anti-RAB8A antibodies have Western blot images: M02180 in HeLa lysate and PA2280 in Caco-2, HepG2, and A549 lysates. PA2280’s caption reports a band near 24 kDa. The supplied evidence does not establish orthogonal specificity.
Which to pick: For human lysates, PA2280 has a detailed WB example using 50 μg of lysate per lane and 0.5 μg/mL antibody; M02180 has a HeLa image. For mouse or rat, M02180 lists reactivity, but its shown WB sample is human.